Theriva™ biologics to host conference call and webcast to discuss full year 2023 operational highlights and financial results

Rockville, md., march 19, 2024 (globe newswire) -- theriva™ biologics (nyse american: tovx), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that it plans to host a conference call on monday, march 25, 2024, at 8:30 a.m. et to discuss its financial results for the full year ended december 31, 2023 and provide a corporate update.
TOVX Ratings Summary
TOVX Quant Ranking